大韓民国で最高の強皮症に対する幹細胞移植術医師 - トップ2名の医師

Dr. Joo-young Park, MD
Chief Medical Director & CEO, BIOFACE Clinic
 

Professional Profile

Board-certified dermatologist and anti-aging specialist with over a decade of clinical and research leadership. Dr. Park combines expertise in laser systems, injectable aesthetics, thread-lift techniques, and regenerative therapies to deliver evidence-based protocols that prioritize patient safety, comfort, and natural, lasting outcomes. A sought-after educator and consultant, he has trained hundreds of clinicians and guided protocol development for leading medical device and biotech firms.

Education & Training

Dermatology Residency, Seoul National University Hospital
Advanced training in laser therapies, injectables, and anti-aging procedures

Medical Student Summer Program, Samsung Medical Center (Sungkyunkwan Univ.)

KSKCS Non-invasive Cosmetic Surgery Course

KCCS Asian Lipoplasty Workshop

Professional Experience

Founder, CEO & Medical Director, BioFace Clinic (2018–Present)
Lead all clinical operations, research initiatives, and strategic growth both domestically and internationally.

QOFill Filler Educator, JW Pharmaceutical (2016–Present)
Deliver hands-on workshops on safe, precise filler injection techniques to over 300 physicians nationwide.

HIFU Lifting Technology Consultant (2017–Present)
Advise device manufacturers on protocol optimization to maximize lift efficacy while minimizing downtime.

Clinical Advisor, L&C BIO (KOSDAQ-listed) (2019–Present)
Design and analyze clinical trials for novel dermatologic injectables.

Clinical Advisor, UTI (Application Specialist)
Provide scientific support and training for UTI’s aesthetic device portfolio.

Technical Consultant, NewThera
Guide R&D and protocol development for next-generation aesthetic injectables.

Invited Lectures & Publications

Invited Speaker, Medical Asia 2016
“Next-Generation Filler Strategies” presented to 500+ regional aesthetic practitioners.

Key Publication:
Kim JW, Li MH, Jang JH, et al.
15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.
Biochem Pharmacol. 2008;76(11):1577–1589.

Academic & Professional Memberships

Korean Academy of Laser Medicine

World Society for Laser Medicine & Surgery

Korean Society for Hair Research

Korean Society of Anti-Aging Dermatology

Korean Society of Obesity & Aesthetic Treatment

Korean Society of Obesity & Body Shaping

Korean Society for Stem Cell Therapy

Korean Society of Primary Care

Select Achievements

Developed research-driven, multi-modal anti-aging protocols integrating lasers, injectables, thread lifts, and stem-cell boosters.

Trained 300+ physicians in advanced filler and HIFU applications, elevating national standards of care.

Received the Korean Society of Aesthetic Medicine’s Excellence in Education Award.

Served as medical advisor on KBS health documentary series and multiple international media features.

Core Competencies

Evidence-Based Protocols: Continuous refinement through outcome analysis of thousands of patient cases

Integrated Anti-Aging: Holistic treatment plans tailored for minimal discomfort and rapid recovery

Educational Leadership: Curriculum design and delivery for clinician workshops and medical symposia

Strategic Consulting: Product development guidance for device manufacturers and biotech firms

Languages & Continuing Education

Languages: Korean (native), English (fluent)

Continuing Education: Regular faculty at international conferences; numerous peer-reviewed publications in leading dermatology journals.

Key International Publication
Kim JW, Li MH, Jang JH, Na HK, Song NY, Lee C, Johnson JA, Surh YJ.
“15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.”
Biochemical Pharmacology. 2008 Dec 1;76(11):1577–1589.

International Conference Presentations

The International Meeting of the Society for Free Radical Research–Asia, Nov 6–8, 2003, Seoul, Korea

The 3rd International Congress of the Asian Society of Toxicology, Feb 1–6, 2003, Bangkok & Chiang Mai, Thailand

Domestic Conference Presentations

The Pharmaceutical Society of Korea Annual Meeting, Oct 10–11, 2003, Seoul, Korea

The 19th Annual Meeting of the Korean Societies of Toxicology, May 30, 2003, Seoul, Korea

The 20th Annual Meeting of the Korean Societies of Toxicology, Oct 30, 2003, Seoul, Korea

The 58th Annual Fall Meeting of the Korean Pediatric Society, Oct 23–24, 2009, Sheraton Walkerhill, Seoul, Korea

The Annual Fall Meeting of the Korean Academy of Family Medicine, Oct 10–12, 2014, Seoul, Korea